Literature DB >> 6037131

Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus.

D Alarcón-Segovia, K G Wakim, J W Worthington, L E Ward.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6037131     DOI: 10.1097/00005792-196701000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
  17 in total

1.  Trigger factors and HL-A antigens in chronic active hepatitis.

Authors:  J Lindberg; A Lindholm; P Lundin; S Iwarson
Journal:  Br Med J       Date:  1975-10-11

Review 2.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

3.  Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion.

Authors:  J T Hardee; C A Roldan; T W Du Clos
Journal:  West J Med       Date:  1997-08

4.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

5.  Acute laryngeal stridor with respiratory arrest in drug induced systemic lupus erythematosus.

Authors:  W K Chong; A G Dewhurst; J R Dathan
Journal:  BMJ       Date:  1988-09-10

6.  Drug-induced lupus erythematosus.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1970-04       Impact factor: 1.967

Review 7.  Drug-induced lupus.

Authors:  E J Price; P J Venables
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

8.  Slow turnover of manganese in active rheumatoid arthritis accelerated by prednisone.

Authors:  G C Cotzias; P S Papavasiliou; E R Hughes; L Tang; D C Borg
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

9.  Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

Review 10.  Drug-induced antinuclear antibodies and lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.